Cargando…
Development of an Improved Method for the Determination of Iodine/β-Cyclodextrin by Means of HPLC-UV: Validation and the Thyroid-Stimulating Activity Revealed by In Vivo Studies
Iodine, being an intrinsic part of thyroid hormones, is a vital microelement required for normal growth and development, particularly in children. Inadequate daily intake of iodine causes iodine deficiency, which is responsible for several health disorders, such as cretinism and goiters. Therefore,...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309194/ https://www.ncbi.nlm.nih.gov/pubmed/34201915 http://dx.doi.org/10.3390/pharmaceutics13070955 |
_version_ | 1783728465143398400 |
---|---|
author | Sharipov, Avez Boboev, Zufar Fazliev, Sunnatullo Gulyamov, Shokhid Yunuskhodjayev, Akhmatkhodja Razzokov, Jamoliddin |
author_facet | Sharipov, Avez Boboev, Zufar Fazliev, Sunnatullo Gulyamov, Shokhid Yunuskhodjayev, Akhmatkhodja Razzokov, Jamoliddin |
author_sort | Sharipov, Avez |
collection | PubMed |
description | Iodine, being an intrinsic part of thyroid hormones, is a vital microelement required for normal growth and development, particularly in children. Inadequate daily intake of iodine causes iodine deficiency, which is responsible for several health disorders, such as cretinism and goiters. Therefore, the development of new drugs and/or food supplements for iodine deficiency is crucial. We synthesized an iodine/β-cyclodextrin complex based on a host–guest model, and in this paper, we outline the development of a new quantitative analysis method. We suggest a robust and reliable high-performance liquid chromatography method to determine the total amount of iodine species in the complex. Moreover, we performed validation of our method. The results of validation presented here show the reliability, accuracy and high precision of the method. Furthermore, for the first time, we show results of in vivo studies for the thyroid-stimulating activity of the iodine/β-cyclodextrin complex. Our findings indicate that the thyroid-stimulating activity of iodine/β-cyclodextrin is comparable to that of potassium iodide, which is the main active pharmaceutical substance of conventional drugs for iodine deficiency. |
format | Online Article Text |
id | pubmed-8309194 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83091942021-07-25 Development of an Improved Method for the Determination of Iodine/β-Cyclodextrin by Means of HPLC-UV: Validation and the Thyroid-Stimulating Activity Revealed by In Vivo Studies Sharipov, Avez Boboev, Zufar Fazliev, Sunnatullo Gulyamov, Shokhid Yunuskhodjayev, Akhmatkhodja Razzokov, Jamoliddin Pharmaceutics Article Iodine, being an intrinsic part of thyroid hormones, is a vital microelement required for normal growth and development, particularly in children. Inadequate daily intake of iodine causes iodine deficiency, which is responsible for several health disorders, such as cretinism and goiters. Therefore, the development of new drugs and/or food supplements for iodine deficiency is crucial. We synthesized an iodine/β-cyclodextrin complex based on a host–guest model, and in this paper, we outline the development of a new quantitative analysis method. We suggest a robust and reliable high-performance liquid chromatography method to determine the total amount of iodine species in the complex. Moreover, we performed validation of our method. The results of validation presented here show the reliability, accuracy and high precision of the method. Furthermore, for the first time, we show results of in vivo studies for the thyroid-stimulating activity of the iodine/β-cyclodextrin complex. Our findings indicate that the thyroid-stimulating activity of iodine/β-cyclodextrin is comparable to that of potassium iodide, which is the main active pharmaceutical substance of conventional drugs for iodine deficiency. MDPI 2021-06-25 /pmc/articles/PMC8309194/ /pubmed/34201915 http://dx.doi.org/10.3390/pharmaceutics13070955 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Sharipov, Avez Boboev, Zufar Fazliev, Sunnatullo Gulyamov, Shokhid Yunuskhodjayev, Akhmatkhodja Razzokov, Jamoliddin Development of an Improved Method for the Determination of Iodine/β-Cyclodextrin by Means of HPLC-UV: Validation and the Thyroid-Stimulating Activity Revealed by In Vivo Studies |
title | Development of an Improved Method for the Determination of Iodine/β-Cyclodextrin by Means of HPLC-UV: Validation and the Thyroid-Stimulating Activity Revealed by In Vivo Studies |
title_full | Development of an Improved Method for the Determination of Iodine/β-Cyclodextrin by Means of HPLC-UV: Validation and the Thyroid-Stimulating Activity Revealed by In Vivo Studies |
title_fullStr | Development of an Improved Method for the Determination of Iodine/β-Cyclodextrin by Means of HPLC-UV: Validation and the Thyroid-Stimulating Activity Revealed by In Vivo Studies |
title_full_unstemmed | Development of an Improved Method for the Determination of Iodine/β-Cyclodextrin by Means of HPLC-UV: Validation and the Thyroid-Stimulating Activity Revealed by In Vivo Studies |
title_short | Development of an Improved Method for the Determination of Iodine/β-Cyclodextrin by Means of HPLC-UV: Validation and the Thyroid-Stimulating Activity Revealed by In Vivo Studies |
title_sort | development of an improved method for the determination of iodine/β-cyclodextrin by means of hplc-uv: validation and the thyroid-stimulating activity revealed by in vivo studies |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309194/ https://www.ncbi.nlm.nih.gov/pubmed/34201915 http://dx.doi.org/10.3390/pharmaceutics13070955 |
work_keys_str_mv | AT sharipovavez developmentofanimprovedmethodforthedeterminationofiodinebcyclodextrinbymeansofhplcuvvalidationandthethyroidstimulatingactivityrevealedbyinvivostudies AT boboevzufar developmentofanimprovedmethodforthedeterminationofiodinebcyclodextrinbymeansofhplcuvvalidationandthethyroidstimulatingactivityrevealedbyinvivostudies AT fazlievsunnatullo developmentofanimprovedmethodforthedeterminationofiodinebcyclodextrinbymeansofhplcuvvalidationandthethyroidstimulatingactivityrevealedbyinvivostudies AT gulyamovshokhid developmentofanimprovedmethodforthedeterminationofiodinebcyclodextrinbymeansofhplcuvvalidationandthethyroidstimulatingactivityrevealedbyinvivostudies AT yunuskhodjayevakhmatkhodja developmentofanimprovedmethodforthedeterminationofiodinebcyclodextrinbymeansofhplcuvvalidationandthethyroidstimulatingactivityrevealedbyinvivostudies AT razzokovjamoliddin developmentofanimprovedmethodforthedeterminationofiodinebcyclodextrinbymeansofhplcuvvalidationandthethyroidstimulatingactivityrevealedbyinvivostudies |